These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8733592)

  • 1. Species specificity in the blood cholesterol-lowering effect of YM-16638.
    Goto S; Shimokawa T; Ugawa T; Hisamichi N; Masuyama Y; Iizumi Y; Sato N; Takenaka T; Kodama T
    Br J Pharmacol; 1996 May; 118(1):174-8. PubMed ID: 8733592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the hypocholesterolemic agent YM-16638 on cholesterol biosynthesis activity and apolipoprotein B secretion in HepG2 and monkey liver.
    Goto S; Shimokawa T
    Jpn J Pharmacol; 1999 Jan; 79(1):75-82. PubMed ID: 10082320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological properties of the orally active leukotriene antagonist [[5-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propyl]thio]-1,3,4- thiadiazol-2-yl]thio]acetic acid.
    Tomioka K; Yamada T; Mase T; Hara H; Murase K
    Arzneimittelforschung; 1988 May; 38(5):682-5. PubMed ID: 3415708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the cholesterol-lowering effects and toxicity of D-003 and lovastatin in normocholesterolaemic rabbits.
    Gámez R; Mendoza S; Mas R; Noa M; Arruzazabala L; Carbajal D; Castaño G; Goicochea E; Mesa M; Mendoza N
    Drugs R D; 2003; 4(4):219-29. PubMed ID: 12848586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocholesterolaemic and antiatherosclerotic effects of tetra-iso-propyl 2-(3,5-di-tert-butyl-4-hydroxyphenyl)ethyl-1,1-diphosphonate (SR-9223i).
    Jackson B; Gee AN; Guyon-Gellin Y; Niesor E; Bentzen CL; Kerns WD; Suckling KE
    Arzneimittelforschung; 2000 Apr; 50(4):380-6. PubMed ID: 10800637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YM-53601, a novel squalene synthase inhibitor, reduces plasma cholesterol and triglyceride levels in several animal species.
    Ugawa T; Kakuta H; Moritani H; Matsuda K; Ishihara T; Yamaguchi M; Naganuma S; Iizumi Y; Shikama H
    Br J Pharmacol; 2000 Sep; 131(1):63-70. PubMed ID: 10960070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YM-53601, a novel squalene synthase inhibitor, suppresses lipogenic biosynthesis and lipid secretion in rodents.
    Ugawa T; Kakuta H; Moritani H; Inagaki O; Shikama H
    Br J Pharmacol; 2003 May; 139(1):140-6. PubMed ID: 12746232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminophenyl ether compound (YM-95831), a new hypolipidemic agent with a high density lipoprotein elevating activity in rats.
    Ohata I; Sakamoto N; Nitatori R; Maeno H
    Arzneimittelforschung; 1983; 33(2):237-41. PubMed ID: 6682662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental model of escape phenomenon in hamsters and the effectiveness of YM-53601 in the model.
    Ugawa T; Kakuta H; Moritani H; Shikama H
    Br J Pharmacol; 2002 Mar; 135(6):1572-8. PubMed ID: 11906972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single and repeated intravenous toxicity studies of pamiteplase (genetical recombination) in rats and monkeys.
    Ishikawa A; Ohata T; Imamura K; Iwasaki M; Sakai T; Matsuzawa T; Okazaki S
    J Toxicol Sci; 1997 May; 22(2):117-33. PubMed ID: 9198009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary dose finding study for subacute toxicological study of pravastatin sodium in monkeys.
    Manabe S; Sudo S; Yamashita K; Miyakoshi N; Matsunuma N; Masuda H
    J Toxicol Sci; 1989 Aug; 14 Suppl 1():41-55. PubMed ID: 2509724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of chronic treatment with the leukotriene D4 antagonist compound LY171883 on Fischer 344 rats and rhesus monkeys.
    Hoover DM; Bendele AM; Hoffman WP; Foxworthy PS; Eacho PI
    Fundam Appl Toxicol; 1990 Jan; 14(1):123-30. PubMed ID: 2307311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of an orally active leukotriene (LT) antagonist YM-16638 on antigen-induced early and late airway responses in allergic sheep.
    Tomioka K; Garrido R; Stevenson JS; Abraham WM
    Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):43-7. PubMed ID: 2740413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel non-systemic inhibitor of ileal apical Na+-dependent bile acid transporter reduces serum cholesterol levels in hamsters and monkeys.
    Kitayama K; Nakai D; Kono K; van der Hoop AG; Kurata H; de Wit EC; Cohen LH; Inaba T; Kohama T
    Eur J Pharmacol; 2006 Jun; 539(1-2):89-98. PubMed ID: 16687134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased fecal bile acid excretion and changes in the circulating bile acid pool are involved in the hypocholesterolemic and gallstone-preventive actions of psyllium in hamsters.
    Trautwein EA; Kunath-Rau A; Erbersdobler HF
    J Nutr; 1999 Apr; 129(4):896-902. PubMed ID: 10203567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of co-administration of simvastatin and alcohol in rats.
    Kolovou GD; Mikhailidis DP; Daskalova DC; Kafaltis N; Adamopoulou EN; Malakos J; Bilianou HG; Theocharis SE; Pilatis ND; Mykoniatis MG; Cokkinos DV
    In Vivo; 2003; 17(6):523-7. PubMed ID: 14758716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical characterization of 2-[3-[3-[(5-ethyl-4'-fluoro-2-hydroxy[1,1'-biphenyl]-4-yl)oxy]propoxy]-2-propylphenoxy]benzoic acid metabolism: in vitro species comparison and in vivo disposition in rats.
    Perkins EJ; Cramer JW; Farid NA; Gadberry MG; Jackson DA; Mattiuz EL; O'Bannon DD; Weiss HJ; Wheeler WJ; Wood PG; Cassidy KC
    Drug Metab Dispos; 2003 Nov; 31(11):1382-90. PubMed ID: 14570771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypocholesterolemic effect of exogenous dehydroepiandrosterone administration in the rhesus monkey.
    Haffa AL; MacEwen EG; Kurzman ID; Kemnitz JW
    In Vivo; 1994; 8(6):993-7. PubMed ID: 7772752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple mechanisms of hypocholesterolemic action of pactimibe, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor.
    Kitayama K; Koga T; Inaba T; Fujioka T
    Eur J Pharmacol; 2006 Aug; 543(1-3):123-32. PubMed ID: 16814766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thirteen-week inhalation toxicity of N,N-dimethylformamide in F344/N rats and B6C3F1 mice.
    Lynch DW; Placke ME; Persing RL; Ryan MJ
    Toxicol Sci; 2003 Apr; 72(2):347-58. PubMed ID: 12655034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.